Arsenic trioxide Intravenous and Hydrochlorothiazide and irbesartan
Determining the interaction of Arsenic trioxide Intravenous and Hydrochlorothiazide and irbesartan and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using arsenic trioxide together with hydroCHLOROthiazide can increase the risk of an irregular heart rhythm that may be serious. If your doctor prescribes these medications together, you may need regular monitoring of your electrolyte (magnesium, potassium) levels as well as other tests to safely use both medications. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, or fast or pounding heartbeats during treatment with arsenic trioxide. In addition, you should let your doctor know if you experience signs of electrolyte disturbance such as weakness, tiredness, drowsiness, confusion, muscle pain, cramps, dizziness, nausea, or vomiting. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR CLOSELY: Arsenic trioxide can cause QT interval prolongation and complete atrioventricular block. Since hypokalemia and hypomagnesemia are known risk factors for arrhythmia associated with QT prolongation, coadministration of arsenic trioxide with agents that can cause significant potassium and/or magnesium loss (e.g., potassium-wasting diuretics, amphotericin B, cation exchange resins) may increase the risk of ventricular arrhythmias such as torsade de pointes and sudden death.
MANAGEMENT: Caution is advised if arsenic trioxide must be used concomitantly with medications that can cause significant potassium and/or magnesium loss. Serum electrolytes should be evaluated and any abnormalities corrected prior to initiating therapy with arsenic trioxide. During therapy, potassium concentrations should be kept above 4 mEq/dL and magnesium concentrations above 1.8 mg/dL. Patients should also have frequent ECGs and be monitored for serious arrhythmias when QT intervals are prolonged. Patients should be advised to seek medical attention if they experience symptoms that could indicate the occurrence of torsade de pointes such as dizziness, palpitations, or syncope.
- Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5
- "Product Information. Trisenox (arsenic trioxide)" Cephalon Inc, West Chester, PA.
Generic Name: arsenic trioxide
Brand name: Trisenox
Synonyms: Arsenic trioxide, Arsenic Trioxide
Generic Name: hydrochlorothiazide / irbesartan
Brand name: Avalide
Synonyms: Irbesartan and Hydrochlorothiazide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Arsenic trioxide Intravenous-Hydrochlorothiazide and lisinopril
- Arsenic trioxide Intravenous-Hydrochlorothiazide and losartan
- Arsenic trioxide Intravenous-Hydrochlorothiazide and methyldopa
- Arsenic trioxide Intravenous-Hydrochlorothiazide and metoprolol
- Arsenic trioxide Intravenous-Hydrochlorothiazide and moexipril
- Arsenic trioxide Intravenous-Hydrochlorothiazide and olmesartan
- Hydrochlorothiazide and irbesartan-Artane
- Hydrochlorothiazide and irbesartan-Artemether and lumefantrine
- Hydrochlorothiazide and irbesartan-Arthricare Cream
- Hydrochlorothiazide and irbesartan-Arthricare For Women Topical
- Hydrochlorothiazide and irbesartan-Arthriten
- Hydrochlorothiazide and irbesartan-Arthritis Pain